Aspirin for Postpartum Patients With Preeclampsia (ASAPP)
Preeclampsia Postpartum
About this trial
This is an interventional treatment trial for Preeclampsia Postpartum focused on measuring Preeclampsia, Postpartum, Aspirin, sFlt-1
Eligibility Criteria
Inclusion Criteria: Preeclampsia with severe features diagnosed during delivery admission, as defined by ACOG criteria. Pre- and postnatal care provided by the Long Beach Memorial Ob/Gyn resident or Maternal-Fetal Medicine clinic. Exclusion Criteria: Patient age <18 years old Non-English or Non-Spanish speaking Chronic hypertension diagnosed before 20 weeks' gestation Known allergy, prior adverse reaction, or any medical condition in which aspirin is contraindicated (nasal polyps, gastric or duodenal ulcers, history of gastrointestinal bleeding, severe hepatic dysfunction) Aspirin prescribed postpartum for any other medical condition Bleeding disorder Breastfeeding an infant with thrombocytopenia
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Standard blood pressure control plus aspirin 81 mg
Standard blood pressure control
Standardized postpartum blood pressure control Aspirin 81 mg by mouth x 1 week post-delivery
Standardized postpartum blood pressure control